Phase 1/1b, Multicenter, Open-Label, Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717 · ACTIVE NOT RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Revolution Medicines Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Revolution Medicines Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Revolution Medicines Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Revolution Medicines Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.